Managing Idiopathic Acute Pancreatitis

• by Doug Brunk

• February 9, 2026

FDA Grants Traditional Approval to Iptacopan in Primary IgAN

Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.

• by Kathryn Wighton

• July 17, 2026

• 2 min

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min

Respiratory Complaints Linked to Delayed Fibrotic ILD Diagnosis

A retrospective cohort study linked repeated respiratory complaints and gastroesophageal reflux disease with longer time to fibrotic interstitial lung disease diagnosis.

• by Andrea Surnit

• August 5, 2026

• 4 min